PROVIDER PROFILE · NPI 1427035286
Francis FarrayeM.D.
PRESCRIBING · PART D · 2024
Total Rx claims
147
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
6
Brand share
51.7%
Top prescribed drugs
Ustekinumab38 claims
Mesalamine37 claims
Sodium, Potassium,mag Sulfates27 claims
Balsalazide Disodium21 claims
Omeprazole13 claims
QUALITY · MIPS · 2024
Final MIPS score
84.2
Quality
74.8
Cost
72.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
CROSS-REFERENCE